Cachexia in chronic heart failure: endocrine determinants and treatment perspectives (Q38035745)

27 August 2017

title

Cachexia in chronic heart failure: endocrine determinants and treatment perspectives (English)

1 reference

27 August 2017

0 references

chronic heart failure

1 reference

Norman Mangner

1

1 reference

27 August 2017

Yae Matsuo

series ordinal

2

1 reference

27 August 2017

Gerhard Schuler

series ordinal

3

1 reference

27 August 2017

Volker Adams

series ordinal

4

1 reference

27 August 2017

publication date

19 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

43

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

253-265

1 reference

Cachexia: a new definition

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Wasting as independent risk factor for mortality in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Effect of branched-chain amino acids on muscle atrophy in cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Ca(2+)-dependent proteolysis in muscle wasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Role of inflammation in the progression of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Inflammatory pathways in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Cancer cachexia is regulated by selective targeting of skeletal muscle gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Tumors secreting human TNF/cachectin induce cachexia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Interleukin-6 and cachexia in ApcMin/+ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Toll-like receptor 4 mediates LPS-induced release of nitric oxide and tumor necrosis factor-alpha by embryonal cardiomyocytes: biological significance and clinical implications in human pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

The emerging role of the gut in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Altered intestinal function in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Intracellular signaling during skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Mechanisms and genes of cellular suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Skeletal muscle apoptosis in experimental heart failure: the only link between inflammation and skeletal muscle wastage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

TNF-R1 signaling: a beautiful pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Exercise capacity in chronic heart failure patients is related to active gene transcription in skeletal muscle and not apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Future prospects of anticytokine therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Effect of thalidomide in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Agents targeting inflammation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Mechanism of induction of muscle protein degradation by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Double muscling in cattle due to mutations in the myostatin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Myostatin mutation associated with gross muscle hypertrophy in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Induction of cachexia in mice by systemically administered myostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Regulation of muscle mass by follistatin and activins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Multiple defects and perinatal death in mice deficient in follistatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Functional improvement of dystrophic muscle by myostatin blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Inhibition of myostatin in adult mice increases skeletal muscle mass and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Overview of insulin-like growth factor physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Molecular mechanisms modulating muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Signal-transduction networks and the regulation of muscle protein degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Adiponectin receptor binding proteins – recent advances in elucidating adiponectin signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Signaling pathways in skeletal muscle remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

A placebo-controlled study of growth hormone in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Increased mortality associated with growth hormone treatment in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Androgens in men--uses and abuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Androgens for postmenopausal women's health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Testosterone and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Low circulating androgens and mortality risk in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Testosterone supplementation in heart failure: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Reversal of COPD-associated weight loss using the anabolic agent oxandrolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Absence of insulin signalling in skeletal muscle is associated with reduced muscle mass and function: evidence for decreased protein synthesis and not increased degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Insulin sensitivity, hormonal levels and skeletal muscle protein metabolism in tumour-bearing exercising rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Insulin resistance and risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Molecular determinants of skeletal muscle mass: getting the "AKT" together

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Ghrelin and the short- and long-term regulation of appetite and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Leptin: a review of its peripheral actions and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Brain regulation of appetite and satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Hyperleptinaemia in chronic heart failure. Relationships with insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Leptin as a new diagnostic tool in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Leptin signaling in the failing and mechanically unloaded human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Leptin deficiency produces contrasting phenotypes in bones of the limb and spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Analysis of an expression profile of genes in the human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Adiponectin inhibits endothelial synthesis of interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Adipokines and systemic inflammation in weight-losing lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Circulating adiponectin concentrations in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Adiponectin acts in the brain to decrease body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Exercise training reduces circulating adiponectin levels in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Anabolic effects of exercise training in patients with advanced chronic heart failure (NYHA IIIb): impact on ubiquitin-protein ligases expression and skeletal muscle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Acute stimulation of glucose metabolism in mice by leptin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9767-Z

Physical training reduces peripheral markers of inflammation in patients with chronic heart failure

21 January 2018

1 reference

12 December 2020

Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting

1 reference

12 December 2020

1 reference

12 December 2020

Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival

1 reference

12 December 2020

Ghrelin strongly stimulates growth hormone release in humans

1 reference

12 December 2020

NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes

1 reference

12 December 2020

Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting

1 reference

12 December 2020

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

12 December 2020

Leptin gene transfer regulates fibromuscular development and lipid deposition in muscles via SIRT1, FOXO3a and PGC-1α in mice in vivo.

1 reference

12 December 2020

Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure

1 reference

12 December 2020

Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system

1 reference

12 December 2020

Effects of IL-10 and age on IL-6, IL-1beta, and TNF-alpha responses in mouse skeletal and cardiac muscle to an acute inflammatory insult

1 reference

12 December 2020

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

12 December 2020

Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility

1 reference

12 December 2020

Systemic inflammation in patients with heart failure

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice

1 reference

12 December 2020

Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse

1 reference

12 December 2020

Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure

1 reference

12 December 2020

A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

1 reference

12 December 2020

Plasma cytokine parameters and mortality in patients with chronic heart failure

1 reference

12 December 2020

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

1 reference

12 December 2020

Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity

1 reference

12 December 2020

How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH

1 reference

12 December 2020

Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO

1 reference

12 December 2020

Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure

1 reference

12 December 2020

Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.

1 reference

12 December 2020

Cardiac failure responding to growth hormone

1 reference

12 December 2020

Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography

1 reference

12 December 2020

Myostatin signals through Pax7 to regulate satellite cell self-renewal

1 reference

12 December 2020

Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure

1 reference

12 December 2020

Blood flow restriction during low-intensity resistance exercise increases S6K1 phosphorylation and muscle protein synthesis

1 reference

12 December 2020

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

1 reference

12 December 2020

Angiotensin II directly inhibits protein synthesis in murine myotubes

1 reference

12 December 2020

Endurance training increases metabolic rate and norepinephrine appearance rate in older individuals.

1 reference

12 December 2020

Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease

1 reference

12 December 2020

Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats

1 reference

12 December 2020

Insulin resistance: a contributing factor to age-related muscle mass loss?

1 reference

12 December 2020

Energy expenditure and symptom severity in men with heart failure

1 reference

12 December 2020

Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance

1 reference

12 December 2020

Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants.

1 reference

12 December 2020

Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha

1 reference

12 December 2020

Insulin‐like growth factor axis (insulin‐like growth factor‐I/insulin‐like growth factor‐binding protein‐3) as a prognostic predictor of heart failure: association with adiponectin

1 reference

12 December 2020

Phosphorylation of p70(S6k) correlates with increased skeletal muscle mass following resistance exercise

1 reference

12 December 2020

Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure

1 reference

12 December 2020

Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure

1 reference

12 December 2020

Treatment of end-stage cardiac failure with growth hormone

1 reference

12 December 2020

10.1007/S12020-012-9767-Z

Identifiers

DOI

1 reference

27 August 2017

1 reference